MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Using mediation analysis to account for the effect of Parkinson’s Disease medications on disease progression

    T. Liu, W. Lu, M. Yang, Y. Zhu, T. Dam, W. Hirst (Cambridge, USA)

    Objective: To explore the use of mediation analysis to incorporate L-dopa equivalent daily dose (LEDD) for disease progression of Parkinson’s Disease (PD) in a simulation…
  • 2023 International Congress

    MRgFUS thalamotomy in dystonic and essential tremor: a prospective study with one year follow up

    N. Golfrè Andreasi, A. Braccia, F. Ghielmetti, LM. Romito, R. Cilia, AE. Elia, G. Devigili, G. Messina, V. Levi, S. Rinaldo, M. Corradi, G. Barbiera, F. Paio, M. Stanziano, S. Prioni, P. Amami, M. Fusarpoli, SHM. Piacentini, MG. Bruzzone, M. Grisoli, EFM. Ciceri, R. Eleopra (Milano, Italy)

    Objective: The primary objective of this study was to evaluate the effectiveness of MRgFUS thalamotomy in patients with Dystonic Tremor (DT) compared with patients with…
  • 2023 International Congress

    Directional deep brain stimulation therapy in the long term

    E. Sanesteban Beceiro, A. Fernández Revuelta, E. López Valdés, R. García-Ramos, C. Fernández García, F. Alonso Frech (Madrid, Spain)

    Objective: To describe our long-term clinical experience with directional deep brain stimulation (d-DBS) in patients with advanced Parkinson’s disease (PD) who have been implanted with…
  • 2023 International Congress

    10 year longitudinal change in clinical and biological characteristics of sporadic Parkinson Disease PPMI cohort

    P. Gonzalez-Latapi, T. Simuni, A. Siderowf, J. Fedler, M. Brumm, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

    Objective: To present data on 10 year longitudinal clinical and biological characteristics of sporadic Parkinson Disease (sPD) participants in the Parkinson’s Progression Markers Initiative (PPMI)…
  • 2023 International Congress

    Parkinson’s Disease and Chronic Inflammatory Demyelinating Polyneuropathy: Broadening the Clinical Spectrum of VCP Mutations?

    E. Contaldi, L. Magistrelli, R. Cantello, S. Gallo, F. Vignaroli (Novara, Italy)

    Objective: Valosin-containing protein (VCP) mutation causes a multiorgan disease characterized by inclusion body myopathy, Paget disease and frontotemporal dementia, more rarely by Charcot-Marie-Tooth disease type…
  • 2023 International Congress

    An acoustic-perceptual analysis of speech in clinical PSP phenotypes.

    G. Di Rauso, F. Cavallieri, A. Gessani, D. Fontanesi, S. Coniglio, V. Fioravanti, S. Contardi, E. Menozzi, S. Meletti, F. Antonelli, V. Rispoli, F. Valzania, C. Budriesi (Modena, Italy)

    Objective: To examine the speech profile in a cohort of patients with Progressive Supranuclear Palsy with Richardson’s syndrome (PSP-RS) and PSP with predominant parkinsonism (PSP-P)…
  • 2023 International Congress

    The investigation of a novel video game for identifying mild cognitive impairment in individuals with Parkinson’s disease

    K. Carey, G. Postma, B. Trokthi, C. Maitland (Corinth, USA)

    Objective: To develop a novel video game (VG) prototype that can effectively detect mild cognitive impairment (MCI) in Parkinson’s disease (PD) patients. Background: MCI is…
  • 2023 International Congress

    Chinese proprietary medicine as adjunct treatment for Parkinson’s disease: a systematic review and meta-analysis

    S. Yuen, KK. Chua, SC. Chen, CP. Ho, C. Chan, M. Li (Hong Kong, Hong Kong)

    Objective: To evaluate the effectiveness of Chinese proprietary medicine (CPM) in improving outcomes of Parkinson’s disease (PD). Background: CPM is a finished Chinese herbal medicine…
  • 2023 International Congress

    Comparison of original and revised versions of the University of Pennsylvania Smell Identification Test

    M. Brumm, K. Pierz, W. Aamodt, C. Gochanour, R. Kurth, C. Coffey, T. Foroud, E. Brown, R. Doty, T. Simuni, C. Tanner, K. Marek, A. Siderowf (Iowa City, USA)

    Objective: To assess agreement between the original and revised versions of the University of Pennsylvania Smell Identification Test (UPSIT). Background: Recently published age/sex-specific UPSIT percentiles,…
  • 2023 International Congress

    Effect of multi-strain probiotics on gut microbiome and metabolites in Parkinson’s Disease

    JW. Hor, SY. Lim, CW. Chong, SL. Song, CSJ. Teh, TS. Toh, JL. Lim, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: We investigated the effects of multi-strain probiotics administration on gut microbiome and metabolites, and markers of intestinal permeability and inflammation. Background: Probiotics have been…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley